{
    "hands_on_practices": [
        {
            "introduction": "To fully grasp the severity of symptoms in venous Thoracic Outlet Syndrome (TOS), it is essential to understand the underlying hemodynamics. This exercise uses Poiseuille's law to provide a quantitative foundation, demonstrating how even a modest reduction in vessel radius can cause a dramatic decrease in blood flow. By working through this calculation, you will appreciate the critical relationship between anatomical compression and physiological consequence, particularly the powerful impact of the radius term ($r^4$) on volumetric flow .",
            "id": "4679589",
            "problem": "A patient with suspected Thoracic Outlet Syndrome (TOS) presents with venous congestion during provocative arm abduction, consistent with dynamic compression of the subclavian vein in the costoclavicular space. Duplex ultrasonography demonstrates that, during the provocative position, the effective luminal radius of the subclavian vein decreases by $0.20$ of its baseline value (that is, the new radius is $0.80$ times the baseline radius) while the length of the compressed segment and the driving pressure gradient remain unchanged. Assume the venous blood behaves as a Newtonian fluid and that steady, fully developed, laminar flow through a cylindrical segment is a valid approximation in this context. Under these assumptions, volumetric flow rate $Q$ through a cylindrical conduit is given by Poiseuille’s relation\n\n$$\nQ=\\frac{\\pi r^{4} \\Delta P}{8 \\eta L},\n$$\n\nwhere $r$ is the radius, $\\Delta P$ is the pressure difference across length $L$, and $\\eta$ is the dynamic viscosity. Using this framework and assuming constant $\\Delta P$, $\\eta$, and $L$ between baseline and provocative positioning, determine the proportionate reduction in volumetric flow caused by the radius decrease, expressed as a single decimal fraction relative to baseline. Do not include any units, and do not use a percentage sign in your answer. If you choose to round, round your answer to four significant figures.",
            "solution": "The problem is first validated to ensure it is scientifically grounded, well-posed, and objective.\n\n### Step 1: Extract Givens\n- The luminal radius of the subclavian vein, $r$, decreases by $0.20$ of its baseline value.\n- The new radius, let's call it $r_2$, is $0.80$ times the baseline radius, $r_1$. Thus, $r_2 = 0.80 \\, r_1$.\n- The length of the compressed segment, $L$, remains unchanged.\n- The driving pressure gradient, $\\Delta P$, remains unchanged.\n- The dynamic viscosity of the blood, $\\eta$, is assumed to be constant.\n- The flow is modeled by Poiseuille’s relation: $Q = \\frac{\\pi r^{4} \\Delta P}{8 \\eta L}$.\n- The objective is to determine the proportionate reduction in volumetric flow, $\\frac{Q_1 - Q_2}{Q_1}$.\n\n### Step 2: Validate Using Extracted Givens\n- **Scientifically Grounded:** The problem uses Poiseuille's law, a cornerstone of fluid dynamics, to model blood flow. While blood is a non-Newtonian fluid, modeling it as Newtonian is a standard and acceptable approximation for flow in large arteries and veins, such as the subclavian vein. The clinical scenario described is a classic presentation of venous Thoracic Outlet Syndrome. The problem is based on established principles of biomechanics and physiology.\n- **Well-Posed:** The problem provides a clear mathematical relationship and all necessary conditions to determine a unique solution. The question asks for a specific, calculable quantity (proportionate reduction).\n- **Objective:** The problem is stated using precise, quantitative, and unbiased language.\n\n### Step 3: Verdict and Action\nThe problem is valid. It is a straightforward application of a fundamental fluid dynamics principle to a clinically relevant biomechanical scenario. A complete solution will be provided.\n\nLet the baseline state be denoted by the subscript $1$ and the state during provocative positioning (compression) be denoted by the subscript $2$.\n\nThe volumetric flow rate, $Q$, is given by Poiseuille's law:\n$$\nQ = \\frac{\\pi r^{4} \\Delta P}{8 \\eta L}\n$$\nwhere $r$ is the luminal radius, $\\Delta P$ is the pressure difference, $L$ is the length of the segment, and $\\eta$ is the fluid's dynamic viscosity.\n\nFor the baseline state, the volumetric flow rate, $Q_1$, is:\n$$\nQ_1 = \\frac{\\pi r_1^{4} \\Delta P}{8 \\eta L}\n$$\nwhere $r_1$ is the baseline radius.\n\nDuring the provocative maneuver, the radius is reduced. According to the problem statement, the new radius, $r_2$, is $0.80$ times the baseline radius, $r_1$.\n$$\nr_2 = 0.80 \\, r_1\n$$\nThe problem states that $\\Delta P$, $L$, and $\\eta$ remain unchanged. Therefore, the new volumetric flow rate, $Q_2$, is:\n$$\nQ_2 = \\frac{\\pi r_2^{4} \\Delta P}{8 \\eta L}\n$$\nWe can substitute the expression for $r_2$ into the equation for $Q_2$:\n$$\nQ_2 = \\frac{\\pi (0.80 \\, r_1)^{4} \\Delta P}{8 \\eta L} = (0.80)^4 \\left( \\frac{\\pi r_1^{4} \\Delta P}{8 \\eta L} \\right)\n$$\nRecognizing that the term in the parenthesis is $Q_1$, we can write $Q_2$ in terms of $Q_1$:\n$$\nQ_2 = (0.80)^4 Q_1\n$$\nThe problem asks for the proportionate reduction in volumetric flow. This is defined as the change in flow ($Q_1 - Q_2$) relative to the original flow ($Q_1$).\n$$\n\\text{Proportionate Reduction} = \\frac{Q_1 - Q_2}{Q_1}\n$$\nWe can simplify this expression:\n$$\n\\frac{Q_1 - Q_2}{Q_1} = 1 - \\frac{Q_2}{Q_1}\n$$\nNow, we substitute the relationship $Q_2 = (0.80)^4 Q_1$:\n$$\n\\text{Proportionate Reduction} = 1 - \\frac{(0.80)^4 Q_1}{Q_1} = 1 - (0.80)^4\n$$\nThe final step is to calculate the numerical value.\n$$\n(0.80)^2 = 0.64\n$$\n$$\n(0.80)^4 = (0.64)^2 = 0.4096\n$$\nTherefore, the proportionate reduction is:\n$$\n\\text{Proportionate Reduction} = 1 - 0.4096 = 0.5904\n$$\nThis result indicates that a $20\\%$ decrease in the vessel radius leads to a $59.04\\%$ reduction in volumetric blood flow, everything else being equal. This demonstrates the critical dependence of flow rate on the radius, as described by the $r^4$ term in Poiseuille's law. The answer is given as a decimal fraction with four significant figures.",
            "answer": "$$\n\\boxed{0.5904}\n$$"
        },
        {
            "introduction": "Diagnosing true neurogenic TOS is one of the most challenging aspects of this field, requiring the precise localization of a lesion within the complex brachial plexus. This problem simulates a classic clinical scenario, challenging you to integrate physical examination, imaging, and detailed electrodiagnostic data to pinpoint the site of nerve compression . Mastering this level of diagnostic synthesis is crucial for distinguishing TOS from its mimics and for planning a successful surgical decompression.",
            "id": "4679550",
            "problem": "A $35$-year-old overhead laborer presents with progressive paresthesias in the ulnar digits and medial forearm and hand weakness worsened by arm abduction. Physical examination demonstrates interosseous muscle wasting and weakness ($4/5$) with preserved wrist and finger extension strength. Provocative maneuvers at the thoracic outlet reproduce symptoms. Radiography reveals a cervical rib arising from $C7$ articulating with the first rib. Electromyography (EMG) and Nerve Conduction Studies (NCS) are performed: needle EMG shows fibrillation potentials and chronic neurogenic motor unit changes in the first dorsal interosseous, abductor digiti minimi, and abductor pollicis brevis, while the extensor indicis and abductor pollicis longus are normal. Sensory testing reveals a reduced medial antebrachial cutaneous (MABC) sensory nerve action potential amplitude at $3 \\,\\mu \\text{V}$ (normal > $10 \\,\\mu \\text{V}$) with normal lateral antebrachial cutaneous response at $12 \\,\\mu \\text{V}$. Paraspinal EMG at $T1$ is normal. Based on first principles of peripheral neuroanatomy and neurophysiology, and integrating the above data in the clinical context of suspected neurogenic thoracic outlet syndrome, which lesion localization within the brachial plexus is most consistent with these findings?\n\nA. $T1$ nerve root proximal to the dorsal root ganglion (DRG)\n\nB. Lower trunk of the brachial plexus in the supraclavicular thoracic outlet, predominantly affecting anterior division fibers with relative $T1 > C8$ involvement\n\nC. Medial cord of the brachial plexus in the infraclavicular region\n\nD. Posterior interosseous nerve (PIN) within the proximal forearm\n\nE. Ulnar nerve at the cubital tunnel",
            "solution": "**Solution Derivation**\n\nThe goal is to precisely localize the neurological lesion by integrating the patient's history, physical examination, imaging, and detailed electrodiagnostic findings.\n\n1.  **Analyze the Pattern of Motor and Sensory Deficits:**\n    *   **Motor:** Weakness and wasting are noted in the interosseous muscles, abductor digiti minimi (ADM), and abductor pollicis brevis (APB). These muscles are innervated by the ulnar nerve (interossei, ADM) and the median nerve (APB). Critically, all share a common root value of **T1** (with some C8 contribution). The sparing of wrist/finger extensors (radial nerve territory, C7/C8) further refines the localization away from the posterior cord. This \"Gilliatt-Sumner hand\" pattern points to a lesion proximal to the formation of the median and ulnar nerves, affecting the T1 nerve fibers specifically.\n    *   **Sensory:** Paresthesias are in the medial forearm and ulnar digits. This corresponds to the sensory distribution of the medial antebrachial cutaneous (MABC) nerve and the ulnar nerve. Both nerves originate from the medial cord, which is formed from the lower trunk (C8, T1).\n\n2.  **Interpret Key Electrodiagnostic Findings:**\n    *   **Normal T1 Paraspinal EMG:** The paraspinal muscles are innervated by the dorsal primary rami, which branch from the spinal nerve immediately after it exits the intervertebral foramen. A normal EMG in these muscles proves the lesion is **distal** to the origin of the dorsal ramus. This effectively rules out a typical T1 radiculopathy located within or just proximal to the foramen.\n    *   **Reduced MABC SNAP:** Sensory nerve action potentials (SNAPs) test the integrity of the sensory axon distal to the dorsal root ganglion (DRG), where the neuron's cell body resides. A reduced SNAP indicates a **postganglionic** lesion that has caused axonal damage (Wallerian degeneration). A preganglionic lesion (e.g., root avulsion proximal to the DRG) would result in a normal SNAP.\n    *   **Synthesis:** The combination of a normal T1 paraspinal EMG and a reduced MABC SNAP definitively localizes the lesion to the brachial plexus proper—distal to both the DRG and the branching of the dorsal ramus.\n\n3.  **Evaluate the Options based on the Localized Lesion:**\n    *   **A. T1 nerve root proximal to the dorsal root ganglion (DRG):** Incorrect. This preganglionic location is inconsistent with the reduced MABC SNAP. It would also likely involve the dorsal ramus, causing abnormal paraspinal EMG, which is not the case.\n    *   **B. Lower trunk of the brachial plexus in the supraclavicular thoracic outlet...:** Correct. This location is postganglionic and distal to the dorsal ramus origin. The lower trunk is formed by the C8 and T1 roots and is the structure directly compressed by a cervical rib in the thoracic outlet. A lesion here perfectly explains the involvement of T1-innervated muscles (APB, FDI, ADM) and sensory fibers (MABC, ulnar distribution). The predilection for anterior division fibers explains the sparing of extensors.\n    *   **C. Medial cord of the brachial plexus in the infraclavicular region:** Incorrect. While a medial cord lesion would explain the pattern of weakness and sensory loss, it is less precise. The anatomical culprit (cervical rib) and site of dynamic compression (thoracic outlet) point to a supraclavicular lesion of the lower trunk, which *gives rise* to the medial cord. Option B describes the primary site of injury.\n    *   **D. Posterior interosseous nerve (PIN):** Incorrect. This is a motor branch of the radial nerve. A lesion here would affect forearm extensors (which are normal) and would not cause the observed pattern of hand muscle weakness or any sensory loss.\n    *   **E. Ulnar nerve at the cubital tunnel:** Incorrect. This would not explain the weakness in the median-innervated APB muscle or the sensory loss in the MABC territory (medial forearm).\n\nTherefore, the constellation of findings points unequivocally to a lesion of the lower trunk of the brachial plexus.",
            "answer": "$$\\boxed{B}$$"
        },
        {
            "introduction": "Managing acute effort-induced axillosubclavian thrombosis, or Paget-Schroetter syndrome, is a high-stakes scenario that demands a swift and evidence-based treatment plan. This practice places you in a common clinical decision point following successful thrombolysis, where you must choose the optimal timing for surgical decompression and manage perioperative anticoagulation . Your decision must balance the risk of re-thrombosis against the risk of surgical bleeding to achieve a durable outcome for a young, active patient.",
            "id": "4679531",
            "problem": "A $19$-year-old right-handed competitive baseball pitcher presents with acute right upper extremity swelling and cyanosis after a week of intensified training. Duplex ultrasonography shows axillosubclavian vein thrombosis. Catheter-directed thrombolysis was performed $24$ hours ago, achieving near-complete lysis. Completion venography demonstrates a residual nonocclusive stenosis estimated at approximately $60\\%$ at the costoclavicular space, with dynamic narrowing on abduction. He is currently admitted on a therapeutic intravenous unfractionated heparin infusion with a therapeutic activated partial thromboplastin time. There is no history of malignancy, thrombophilia, or central venous catheter use. Physical examination shows a well-perfused hand and resolving edema; neurologic exam is normal. Laboratory evaluation shows normal platelet count and normal renal function. The surgical team is planning definitive management for venous thoracic outlet syndrome and asks you to select the best strategy for timing of decompression and perioperative anticoagulation that minimizes rethrombosis and bleeding risk while restoring durable venous patency for return to sport.\n\nFrom first principles, consider the pathophysiology of effort-induced axillosubclavian thrombosis (Paget-Schroetter syndrome) as extrinsic venous compression at the thoracic outlet leading to local stasis and endothelial injury (Virchow’s triad), the effects of thrombolysis on clot burden and endothelial integrity, the hemodynamic consequences of persistent anatomic compression, and the pharmacokinetics of unfractionated heparin versus oral agents in the perioperative period. Also consider the goals of definitive management: removal of extrinsic compression, restoration of venous caliber, and prevention of recurrent thrombosis.\n\nWhich of the following management plans is most appropriate?\n\nA. Defer decompression surgery for $6$–$12$ weeks to allow endothelial healing, discharge on a vitamin K antagonist with a heparin bridge, and stop all anticoagulation $24$ hours before surgery without resumption thereafter.\n\nB. Perform first rib resection with scalenectomy and venolysis during the same admission within $48$–$72$ hours after thrombolysis once edema stabilizes; hold the unfractionated heparin infusion $4$–$6$ hours preoperatively, perform intraoperative or immediate postoperative venography with balloon angioplasty of residual stenosis if indicated, and resume systemic anticoagulation postoperatively for $6$–$12$ weeks.\n\nC. Proceed to decompression surgery within $12$ hours of thrombolysis while maintaining uninterrupted full-dose unfractionated heparin throughout the operation to prevent rethrombosis, and discontinue anticoagulation at discharge.\n\nD. Avoid decompression surgery and treat with $3$ months of anticoagulation alone, reserving surgery only if rethrombosis occurs, because thrombolysis has restored patency and long-term outcomes are equivalent without surgery.\n\nE. Schedule decompression more than $14$ days after thrombolysis when venous inflammation has subsided; transition immediately to low-molecular-weight heparin monotherapy for outpatient management, and withhold any postoperative anticoagulation if intraoperative venography shows flow.",
            "solution": "The user has provided a clinical scenario and requested an analysis of the most appropriate management plan based on first principles.\n\n**Problem Statement Validation**\n\nFirst, I will validate the problem statement according to the specified criteria.\n\n**Step 1: Extract Givens**\n- **Patient Profile:** A $19$-year-old, right-handed, competitive baseball pitcher.\n- **Clinical Presentation:** Acute right upper extremity swelling and cyanosis following intensified training.\n- **Diagnostic Findings:** Duplex ultrasonography confirms axillosubclavian vein thrombosis. This presentation in a young athlete constitutes effort-induced thrombosis, or Paget-Schroetter syndrome.\n- **Initial Management:** Catheter-directed thrombolysis was performed $24$ hours prior to the current assessment, achieving near-complete lysis.\n- **Post-Thrombolysis Findings:** Completion venography reveals a residual, nonocclusive stenosis of approximately $60\\%$ at the costoclavicular space, with evidence of dynamic narrowing upon abduction.\n- **Current Status:** The patient is admitted and receiving a therapeutic intravenous unfractionated heparin (UFH) infusion, with a therapeutic activated partial thromboplastin time (aPTT). Physical examination shows resolving edema, a well-perfused hand, and a normal neurologic exam. Laboratory results show a normal platelet count and normal renal function.\n- **Exclusionary History:** No history of malignancy, thrombophilia, or central venous catheter use, solidifying the diagnosis of primary/effort-induced thrombosis.\n- **Objective:** To determine the optimal strategy for timing of surgical decompression and perioperative anticoagulation to achieve durable venous patency, minimize risks of rethrombosis and bleeding, and facilitate return to sport.\n- **Guiding Principles:** Consideration of the pathophysiology (Virchow's triad due to extrinsic compression), effects of thrombolysis, hemodynamics of persistent compression, pharmacokinetics of anticoagulants, and the goals of definitive management (decompression, restoring venous caliber, preventing recurrence).\n\n**Step 2: Validate Using Extracted Givens**\n- **Scientifically Grounded:** The problem describes a classic and well-documented clinical entity, Paget-Schroetter syndrome. The pathophysiology cited (extrinsic compression leading to endothelial injury and stasis) is the accepted model. The diagnostic and therapeutic modalities mentioned (Duplex ultrasound, venography, catheter-directed thrombolysis, heparin) are all standard-of-care. The problem is firmly rooted in established principles of vascular surgery and medicine.\n- **Well-Posed:** The problem provides a clear, self-contained clinical scenario with sufficient data to formulate a management plan. The objective is explicitly stated, and a definitive, evidence-based answer can be derived by comparing the provided options against established treatment principles.\n- **Objective:** The description is factual and clinical, using precise medical terminology without subjective or ambiguous language.\n\n**Step 3: Verdict and Action**\nThe problem statement is **valid**. It is scientifically sound, well-posed, objective, and contains sufficient information to proceed with a solution.\n\n**Derivation of the Optimal Management Strategy from First Principles**\n\nThe pathophysiology of Paget-Schroetter syndrome is central to determining the correct management. The primary pathology is not the thrombosis itself, but the underlying anatomical compression of the subclavian vein, typically within the costoclavicular space (between the first rib and the clavicle). Repetitive motion, as seen in a baseball pitcher, causes chronic microtrauma to the vein's endothelium. This, combined with stasis from compression, fulfills Virchow's triad and precipitates thrombosis.\n\nTherefore, a successful management strategy must address both the acute thrombus and the chronic underlying compression.\n\n1.  **Management of the Thrombus:** The acute clot burden has been addressed by catheter-directed thrombolysis. This is the preferred initial step as it rapidly restores venous outflow, alleviates acute symptoms, and is crucial for preserving long-term valve function and preventing post-thrombotic syndrome. The patient has achieved \"near-complete lysis,\" which is an excellent initial outcome.\n\n2.  **Management of the Underlying Compression:** The completion venogram confirms the persistence of the underlying anatomical problem: a $60\\%$ stenosis at the costoclavicular space that worsens with arm abduction. Anticoagulation alone cannot resolve this mechanical issue. Leaving the compression in place virtually guarantees re-thrombosis, as the freshly lysed, fragile endothelium remains subject to the same injurious forces. Therefore, surgical decompression is mandatory for a durable outcome, especially in a young athlete aiming to return to a high-demand sport. The standard surgical procedure is a transaxillary or supraclavicular first rib resection, often accompanied by anterior scalenectomy and venolysis (freeing the vein from surrounding scar tissue).\n\n3.  **Timing of Surgical Decompression:** The timing of surgery is critical.\n    -   **Delayed Surgery (weeks to months):** An older strategy, now largely abandoned. Waiting for weeks allows the cleared vein to re-thrombose due to the unaddressed compression. This often leads to fibrosis and chronic occlusion, making subsequent surgical intervention far less effective.\n    -   **Immediate Surgery (within hours of lysis):** This carries a high risk of perioperative bleeding. The lytic agents and the denuded endothelium create a pro-hemorrhagic state. A short period of stabilization is prudent.\n    -   **Early Surgery (within days to $2$ weeks):** This is the current consensus and represents the optimal \"window of opportunity.\" Performing surgery during the same admission, typically $24$–$72$ hours after thrombolysis, allows the acute effects of lytics to dissipate and edema to stabilize while the patient is protected from re-thrombosis by a therapeutic heparin infusion. This approach maximizes the chance of preserving a patent, functional vein.\n\n4.  **Perioperative Anticoagulation:**\n    -   **Preoperative:** The patient is on therapeutic UFH. Due to its short biological half-life (approximately $60$–$90$ minutes), the infusion can be stopped $4$–$6$ hours before surgery to ensure adequate intraoperative hemostasis.\n    -   **Intraoperative:** Surgery should not be performed on a fully anticoagulated patient due to the risk of uncontrollable bleeding in a complex anatomical space containing the brachial plexus and major arteries.\n    -   **Postoperative:** Anticoagulation must be resumed postoperatively to prevent re-thrombosis at the site of surgical manipulation and any venous repair. This is typically restarted once surgical hemostasis is deemed secure (usually within $12$–$24$ hours) and continued for a period of weeks to months ($3$–$6$ months is common) to allow for complete endothelial healing.\n\n5.  **Management of Residual Stenosis:** The extrinsic compression has been removed surgically, but the venogram showed a residual $60\\%$ stenosis, likely due to intrinsic scarring from chronic compression. This lesion will impede flow and act as a nidus for re-thrombosis. Therefore, after decompression, the vein must be re-evaluated with venography. If a hemodynamically significant stenosis persists, it must be treated with balloon angioplasty (PTA). Stenting is generally avoided in this location due to the risk of stent fracture and failure from external compressive forces.\n\n**Conclusion of First-Principles Analysis:**\nThe optimal strategy involves a three-pronged approach: thrombolysis, followed by early surgical decompression within the same admission, and assessment/treatment of any residual intrinsic stenosis, all bridged by carefully managed perioperative anticoagulation.\n\n**Evaluation of Provided Options**\n\n**A. Defer decompression surgery for $6$–$12$ weeks to allow endothelial healing, discharge on a vitamin K antagonist with a heparin bridge, and stop all anticoagulation $24$ hours before surgery without resumption thereafter.**\n-   **Analysis:** Deferring surgery for $6$–$12$ weeks carries an unacceptably high risk of irreversible venous re-occlusion due to the persistent anatomical compression. This has been shown to lead to inferior outcomes. Furthermore, not resuming anticoagulation postoperatively ignores the high thrombotic risk to the manipulated and repaired vein.\n-   **Verdict:** **Incorrect**.\n\n**B. Perform first rib resection with scalenectomy and venolysis during the same admission within $48$–$72$ hours after thrombolysis once edema stabilizes; hold the unfractionated heparin infusion $4$–$6$ hours preoperatively, perform intraoperative or immediate postoperative venography with balloon angioplasty of residual stenosis if indicated, and resume systemic anticoagulation postoperatively for $6$–$12$ weeks.**\n-   **Analysis:** This option aligns perfectly with the strategy derived from first principles. The timing ($48$–$72$ hours post-lysis, same admission) is optimal. The management of preoperative heparin (hold $4$–$6$ hours) is correct. The inclusion of venography and angioplasty for residual stenosis is critical for durable patency. The plan for postoperative anticoagulation for $6$–$12$ weeks is appropriate for preventing recurrence during the healing phase.\n-   **Verdict:** **Correct**.\n\n**C. Proceed to decompression surgery within $12$ hours of thrombolysis while maintaining uninterrupted full-dose unfractionated heparin throughout the operation to prevent rethrombosis, and discontinue anticoagulation at discharge.**\n-   **Analysis:** Operating within $12$ hours of lysis is too soon and increases bleeding risk. Performing major surgery with uninterrupted full-dose heparin is contraindicated and extremely dangerous. Discontinuing anticoagulation at discharge would leave the patient vulnerable to re-thrombosis just a few days after complex venous surgery.\n-   **Verdict:** **Incorrect**.\n\n**D. Avoid decompression surgery and treat with $3$ months of anticoagulation alone, reserving surgery only if rethrombosis occurs, because thrombolysis has restored patency and long-term outcomes are equivalent without surgery.**\n-   **Analysis:** This plan fails to address the root cause—the extrinsic compression demonstrated on venography. The premise that outcomes are equivalent without surgery is factually incorrect; conservative management with anticoagulation alone has a high failure rate. Surgery is not a salvage procedure for re-thrombosis but a definitive treatment for the primary anatomical problem.\n-   **Verdict:** **Incorrect**.\n\n**E. Schedule decompression more than $14$ days after thrombolysis when venous inflammation has subsided; transition immediately to low-molecular-weight heparin monotherapy for outpatient management, and withhold any postoperative anticoagulation if intraoperative venography shows flow.**\n-   **Analysis:** Delaying surgery for more than $14$ days, while not as poor as the $6$–$12$ week delay in option A, is suboptimal and increases the risk of re-thrombosis while the patient waits. The most critical flaw is withholding postoperative anticoagulation. Even if venography shows good flow, the endothelial surface is traumatized and requires pharmacological protection during healing.\n-   **Verdict:** **Incorrect**.",
            "answer": "$$\\boxed{B}$$"
        }
    ]
}